BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 31350940)

  • 1. Patterns of care and treatment outcomes for local recurrence of NPC after definite IMRT-A study by the HKNPCSG.
    Ng WT; Wong ECY; Cheung AKW; Chow JCH; Poon DMC; Lai JWY; Chiang CL; Choi HCW; Chau TC; Lee VHF; Lee AWM; Tam AHP; Au KH
    Head Neck; 2019 Oct; 41(10):3661-3669. PubMed ID: 31350940
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Salvage treatment using carbon ion radiation in patients with locoregionally recurrent nasopharyngeal carcinoma: Initial results.
    Hu J; Bao C; Gao J; Guan X; Hu W; Yang J; Hu C; Kong L; Lu JJ
    Cancer; 2018 Jun; 124(11):2427-2437. PubMed ID: 29579324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reirradiation with intensity-modulated radiotherapy for locally recurrent T3 to T4 nasopharyngeal carcinoma.
    Chan OS; Sze HC; Lee MC; Chan LL; Chang AT; Lee SW; Hung WM; Lee AW; Ng WT
    Head Neck; 2017 Mar; 39(3):533-540. PubMed ID: 27898191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endoscopic surgery compared with intensity-modulated radiotherapy in resectable locally recurrent nasopharyngeal carcinoma: a multicentre, open-label, randomised, controlled, phase 3 trial.
    Liu YP; Wen YH; Tang J; Wei Y; You R; Zhu XL; Li J; Chen L; Ling L; Zhang N; Zou X; Hua YJ; Chen YM; Chen L; Lu LX; Chen MY; Wen WP
    Lancet Oncol; 2021 Mar; 22(3):381-390. PubMed ID: 33600761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term outcomes after reirradiation in nasopharyngeal carcinoma with intensity-modulated radiotherapy: A meta-analysis.
    Leong YH; Soon YY; Lee KM; Wong LC; Tham IWK; Ho FCH
    Head Neck; 2018 Mar; 40(3):622-631. PubMed ID: 29130584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment outcomes of nasopharyngeal carcinoma in modern era after intensity modulated radiotherapy (IMRT) in Hong Kong: A report of 3328 patients (HKNPCSG 1301 study).
    Au KH; Ngan RKC; Ng AWY; Poon DMC; Ng WT; Yuen KT; Lee VHF; Tung SY; Chan ATC; Sze HCK; Cheng ACK; Lee AWM; Kwong DLW; Tam AHP
    Oral Oncol; 2018 Feb; 77():16-21. PubMed ID: 29362121
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical outcomes of carbon-ion radiotherapy for patients with locoregionally recurrent nasopharyngeal carcinoma.
    Hu J; Huang Q; Gao J; Guan X; Hu W; Yang J; Qiu X; Chen M; Kong L; Lu JJ
    Cancer; 2020 Dec; 126(23):5173-5183. PubMed ID: 32931035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reirradiation for Recurrent Nasopharyngeal Carcinomas: Experience From an Academic Tertiary Center in a Low- to Middle-Income Country.
    Agas RAF; Yu KKL; Sogono PG; Co LBA; Jacinto JCKM; Bacorro WR; Mejia MBA
    J Glob Oncol; 2019 Feb; 5():1-14. PubMed ID: 30735433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intensity-modulated radiation therapy in the salvage of locally recurrent nasopharyngeal carcinoma.
    Qiu S; Lin S; Tham IW; Pan J; Lu J; Lu JJ
    Int J Radiat Oncol Biol Phys; 2012 Jun; 83(2):676-83. PubMed ID: 22024207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effectiveness of intensity-modulated radiation therapy versus 2D-RT for the treatment of nasopharyngeal carcinoma: A systematic review and meta-analysis.
    Du T; Xiao J; Qiu Z; Wu K
    PLoS One; 2019; 14(7):e0219611. PubMed ID: 31291379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term survival and late complications in intensity-modulated radiotherapy of locally recurrent T1 to T2 nasopharyngeal carcinoma.
    Tian YM; Guan Y; Xiao WW; Zeng L; Liu S; Lu TX; Zhao C; Han F
    Head Neck; 2016 Feb; 38(2):225-31. PubMed ID: 25244494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term outcomes and prognostic factors of re-irradiation for locally recurrent nasopharyngeal carcinoma using intensity-modulated radiotherapy.
    Han F; Zhao C; Huang SM; Lu LX; Huang Y; Deng XW; Mai WY; Teh BS; Butler EB; Lu TX
    Clin Oncol (R Coll Radiol); 2012 Oct; 24(8):569-76. PubMed ID: 22209574
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survival outcome of patients with nasopharyngeal carcinoma with first local failure: a study by the Hong Kong Nasopharyngeal Carcinoma Study Group.
    Yu KH; Leung SF; Tung SY; Zee B; Chua DT; Sze WM; Law SC; Kam MK; Leung TW; Sham JS; Lee AW; Au JS; Hui EP; Sze WK; Cheng AC; Yau TK; Ngan RK; Wong FC; Au GK; Chan AT;
    Head Neck; 2005 May; 27(5):397-405. PubMed ID: 15726589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognosis of nasopharyngeal carcinoma with insufficient radical dose to the primary site in the intensity-modulated radiotherapy era.
    Lu T; Xie X; Guo Q; Zhan S; Lin C; Lin S; Zhang Y; Zong J; Pan J
    Head Neck; 2019 Oct; 41(10):3516-3524. PubMed ID: 31313419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Establishment of prognostic factors in recurrent nasopharyngeal carcinoma patients who received salvage intensity-modulated radiotherapy: A meta-analysis.
    Yue Q; Zhang M; Chen Y; Zheng D; Chen Y; Feng M
    Oral Oncol; 2018 Jun; 81():81-88. PubMed ID: 29884418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Second primary cancer after intensity-modulated radiotherapy for nasopharyngeal carcinoma: A territory-wide study by HKNPCSG.
    Chow JCH; Tam AHP; Cheung KM; Lee VHF; Chiang CL; Tong M; Wong ECY; Cheung AKW; Chan SPC; Lai JWY; Ngan RKC; Ng WT; Lee AWM; Au KH
    Oral Oncol; 2020 Dec; 111():105012. PubMed ID: 32980659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of PLDR-IMRT for the re-irradiation of recurrent NPC: A prospective, single-arm, multicenter trial.
    Huang R; Li Z; Yang F; Zhang Y; Jiang Y; Li C; Gao H; Li G; Liu Y; Guo W; Yang D; Zhang S; Li J; Wen H; Lang J; Zhang P
    Cancer Sci; 2023 Jun; 114(6):2534-2543. PubMed ID: 36788727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term treatment outcome of recurrent nasopharyngeal carcinoma treated with salvage intensity modulated radiotherapy.
    Hua YJ; Han F; Lu LX; Mai HQ; Guo X; Hong MH; Lu TX; Zhao C
    Eur J Cancer; 2012 Dec; 48(18):3422-8. PubMed ID: 22835782
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic model for survival of local recurrent nasopharyngeal carcinoma with intensity-modulated radiotherapy.
    Tian YM; Tian YH; Zeng L; Liu S; Guan Y; Lu TX; Han F
    Br J Cancer; 2014 Jan; 110(2):297-303. PubMed ID: 24335924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyperfractionation compared to standard fractionation in intensity-modulated radiation therapy for patients with locally advanced recurrent nasopharyngeal carcinoma.
    Lee VH; Kwong DL; Leung TW; Ng SC; Lam KO; Tong CC; Sze CK
    Eur Arch Otorhinolaryngol; 2017 Feb; 274(2):1067-1078. PubMed ID: 27738820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.